EMV Capital announced the acquisition and investment into Wanda Inc, a San Francisco-based digital health company commercialising advanced clinical decision support software powered by machine learning and real time patient data analysis.
EMV Capital’s investment will enable Wanda to accelerate its growth in the North American market, as well as to enter the UK and European markets. “I’m excited to welcome Wanda, an innovative digital health company into the EMV Capital family” said Dr. Ilian Iliev managing director of EMV Capital. “Wanda has shown impact and strong traction in the past couple of years and we are excited to support the company’s team through its growth phase. It fits in our investment thesis of backing exciting AI-powered technology platforms that can scale rapidly through industry partnerships.”
“We are delighted to welcome EMV Capital’s smart venture strategy. Their expertise in B2B technology investments and network of corporate partners will support Wanda’s growth stage,” commented Foad Dabiri, Co-Founder and CEO of Wanda. “We are very excited that Wanda has reached a stage where its products and technology have proven their value to our partners and clients and now it is time for the next exciting chapter in its mission.”
Bill Bassett, Chief Commercialization Officer of Wanda noted, “We intend to expand the operations and commercialization efforts of Wanda targeting new provider and payer segments in the health care space. The success experienced by customers including Accountable Care Organizations (ACOs), Post-Acute Care Providers, and Physician Practice Management Companies (PPMC) includes improving people’s quality of life, while reducing the adverse effects of chronic diseases, such as heart failure, and lowering the overall cost of healthcare.”
According to a recent study by the Centers for Disease Control, “$199 billion per year is spent on cardiac disease alone in the US. That amount is projected to grow to $1.1 trillion by 2035 affecting over 131 million persons annually.” 1,2 The global need for remote patient monitoring solutions like Wanda’s is projected to become even more expansive with the global market for Connected Healthcare solutions growing to $105 billion by 2022. 3 Driving this growth is the crisis of chronic conditions lead by heart disease which is estimated to affect 1.1 billion adults globally. 4
Industry reports cited:
1. Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation. 2018;137:e67–e492.
Comments